SA135G51UI10
SA135G51UI10
Dallah Healthcare Co.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 9.55B EUR | 9.26B EUR | 11.26B EUR | 10.57B EUR |
Enterprise Value | 13.5B EUR | 13.4B EUR | 15.09B EUR | 14.3B EUR |
Valuation Multiples | ||||
Trailing P/E | 21.7x | 20.9x | 24.1x | 27.63x |
Forward P/E | 15.3x | -- | -- | -- |
Price to Sales | 2.22x | 2.16x | 2.65x | 3.27x |
Price to Book | 2.29x | 2.24x | 2.75x | 2.59x |
EV/Revenue | 3.15x | 3.12x | 3.55x | 4.42x |
EV/EBITDA | 18.72x | 15.52x | 17.34x | 21.14x |
Price to FCF (P/FCF) | -- | -- | -- | -- |
EV/FCF | -- | -- | -- | -- |
FCF Yield | -6.04% | -0.73% | -0.61% | -0.21% |